Is CBRS a good stock to buy?
Cerebras Systems Inc. · end-of-day data as of Nov 13, 2026
- PT$253.63 +133.3%
- ConsensusBuy · 11
- News
- MACD3.21
- RSI45
- Resistance+57.1%
- Off 52w high-71.9%
- Volume2.9x
- Bollingerupper half
- Trendsideways
- Sector→ -15.8%
- 52w range$78–$386
- ATR+10.6%
- Off ATH-71.9%
- Insiders-$384M
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Cerebras a good stock to buy?
Cerebras is strong on 2 of the 4 questions about the business; weak on advantage and economics. With a loss over the last 12 months, Cerebras has no P/E ratio (Nov 13, 2026). pretickt does not say whether to buy or sell.
- Demand growing
- Advantage easy to copy
- Economics losing money
- Execution no reading
- Fragility sturdy
- Price below its peers
CBRS sales growth revenue growth
+76%in its last fiscal yearCerebras' sales grew 76% in fiscal 2025, to $510M.
CBRS analysts' forecast revenue estimates
+74%the sales they expect next fiscal year, on the lastAnalysts expect Cerebras' sales to grow 74% to $885M in fiscal 2026 (7 analysts).
CBRS return on capital ROIC
pretickt analysis-10%earned before tax on the money invested in it
Cerebras earned -10% before tax on the capital invested in it in the 12 months to Sep 30, 2026; Entegris 15%, ON Semiconductor 10%, Microchip Technology 10% and Qnity Electronics 8%.
CBRS margin on each sale gross margin
30%left after making the productCerebras kept 30% of each sale after making the product in the 12 months to Sep 30, 2026; its competitors' median is 43%.
CBRS margin after costs profit margin
-99%of sales left after running the businessCerebras' operating margin was -99% in the 12 months to Sep 30, 2026, against -35% in fiscal 2024.
CBRS insider selling
-$415Msold, net, by its executives in 12 monthsCerebras' executives and directors sold a net $415M of shares in the 12 months to Nov 13, 2026; none bought.
CBRS financial health Altman Z-score
5.7Altman Z-score, safe above 3Cerebras' Altman Z-score is 5.7 (Nov 13, 2026), above 3, where the safe zone starts.
CBRS price vs profit P/E ratio
—it lost money in 12 months: no P/ECerebras has no P/E ratio: it lost money over the 12 months to Sep 30, 2026.
CBRS price vs assets price to book
2.7×times what its assets are worth on paperCerebras trades at 2.7 times its book value (Nov 13, 2026); its competitors' median is 4.4.
CBRS analysts' target price target
+133%to their average targetAnalysts' average price target for Cerebras is $254, 133% above the Nov 13, 2026 close of $108.72.
CBRS analyst ratings, 90 days
pretickt analysisFreedom Capital Marketsupgrade
In the 90 days to Nov 13, 2026, Freedom Capital Markets upgraded Cerebras.
What is Cerebras' P/E ratio?
Cerebras has no P/E ratio: it lost money over the 12 months to Sep 30, 2026. Cerebras trades at 2.7 times its book value (Nov 13, 2026); its competitors' median is 4.4.
Who are Cerebras' biggest competitors?
pretickt compares Cerebras with Qnity Electronics, Entegris, ON Semiconductor and Microchip Technology. Cerebras' sales grew 80% in the 12 months to Sep 30, 2026, faster than Microchip Technology (+33%), Entegris (+9%) and ON Semiconductor (+3%).
Is Cerebras profitable?
Cerebras' operating margin was -99% in the 12 months to Sep 30, 2026, against -35% in fiscal 2024.
Who is dumping Cerebras stock?
Cerebras' executives and directors sold a net $415M of shares in the 12 months to Nov 13, 2026; none bought.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.